We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$185M
AUM Growth
+$6.35M
Cap. Flow
-$4.39M
Cap. Flow %
-2.37%
Top 10 Hldgs %
41.23%
Holding
94
New
5
Increased
11
Reduced
47
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$3.93M
2
ACN icon
Accenture
ACN
+$492K
3
COF icon
Capital One
COF
+$275K
4
APA icon
APA Corp
APA
+$109K
5
PM icon
Philip Morris
PM
+$67.8K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.7M
2
COO icon
Cooper Companies
COO
+$1.02M
3
STZ icon
Constellation Brands
STZ
+$769K
4
AAPL icon
Apple
AAPL
+$397K
5
EXAS
Exact Sciences
EXAS
+$317K

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Industrials 19.83%
3 Financials 19.25%
4 Healthcare 14.29%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BALL icon
26
Ball Corp
BALL
$17.3B
$2.63M 1.42%
46,883
-1,745
-4% -$91.2K
BWA icon
27
BorgWarner
BWA
$13.1B
$2.59M 1.4%
77,255
-3,620
-4% -$111K
TRP icon
28
TC Energy
TRP
$70.2B
$2.56M 1.38%
52,457
-1,090
-2% -$53.5K
AMGN icon
29
Amgen
AMGN
$208B
$2.41M 1.3%
8,646
-225
-3% -$63.7K
MLM icon
30
Martin Marietta Materials
MLM
$31.5B
$2.2M 1.19%
4,013
-402
-9% -$212K
LYB icon
31
LyondellBasell Industries
LYB
$20B
$2.13M 1.15%
36,835
-440
-1% -$25.6K
AMZN icon
32
Amazon
AMZN
$2.92T
$2.09M 1.13%
9,508
-70
-0.7% -$13.9K
LMT icon
33
Lockheed Martin
LMT
$134B
$2.07M 1.12%
4,475
– –
META icon
34
Meta Platforms (Facebook)
META
$1.42T
$2.06M 1.11%
2,796
+51
+2% +$31.5K
INTC icon
35
Intel
INTC
$455B
$2.05M 1.11%
91,683
-2,250
-2% -$46.6K
ACN icon
36
Accenture
ACN
$102B
$1.99M 1.07%
6,646
+1,615
+32% +$492K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$121B
$1.92M 1.04%
4,306
-275
-6% -$127K
CVS icon
38
CVS Health
CVS
$133B
$1.89M 1.02%
27,397
-725
-3% -$47.5K
CI icon
39
Cigna
CI
$73.7B
$1.72M 0.93%
5,199
-14
-0.3% -$4.51K
QCOM icon
40
Qualcomm
QCOM
$155B
$1.67M 0.9%
10,460
+400
+4% +$58.9K
ORCL icon
41
Oracle
ORCL
$374B
$1.65M 0.89%
7,541
– –
JNJ icon
42
Johnson & Johnson
JNJ
$618B
$1.41M 0.76%
9,210
+112
+1% +$17.2K
J icon
43
Jacobs Solutions
J
$15.9B
$1.39M 0.75%
10,574
-914
-8% -$113K
WFC icon
44
Wells Fargo
WFC
$261B
$1.28M 0.69%
15,968
– –
ZTS icon
45
Zoetis
ZTS
$32.4B
$1.27M 0.69%
8,140
+51
+0.6% +$8.09K
CARR icon
46
Carrier Global
CARR
$51B
$1.14M 0.62%
15,587
-198
-1% -$13.4K
MDT icon
47
Medtronic
MDT
$109B
$984K 0.53%
11,288
-850
-7% -$72.1K
KVUE icon
48
Kenvue
KVUE
$36.9B
$960K 0.52%
45,866
-2,917
-6% -$66.3K
MRK icon
49
Merck
MRK
$322B
$844K 0.46%
10,666
-196
-2% -$15.6K
SIRI icon
50
SiriusXM
SIRI
$9.98B
$791K 0.43%
34,450
-50
-0.1% -$1.08K
1
2
3 4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Lipe & Dalton's Q2 2025 Portfolio in Review

As of Q2 2025, Lipe & Dalton held 94 positions worth $185M, up 3.6% from $179M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Lipe & Dalton's Q2 2025 filing shows 5 new, 11 increased, 47 reduced and 4 closed positions. Its largest new stake was Thermo Fisher Scientific: 9,404 shares worth $3.81M. The largest sale was Bristol-Myers Squibb, an estimated $2.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

  • Lipe & Dalton's largest Q2 2025 buy was Thermo Fisher Scientific: 9,404 shares worth $3.81M.
  • Lipe & Dalton added most to Accenture in Q2 2025, an estimated $492K increase.
  • Lipe & Dalton's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $2.7M.
  • Lipe & Dalton fully exited Cooper Companies in Q2 2025, selling an estimated $1.02M.
  • Lipe & Dalton's ten largest holdings make up 41% of its $185M portfolio in Q2 2025.
  • Lipe & Dalton opened 5 new positions and closed 4 in Q2 2025.
  • Lipe & Dalton's portfolio value rose 3.6% quarter-over-quarter to $185M.

Based on Lipe & Dalton's 13F filing for Q2 2025, filed 1 Aug 2025.